Found: 7
Select item for more details and to access through your institution.
ACC2 is under-expressed in lung adenocarcinoma and predicts poor clinical outcomes.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 3145, doi. 10.1007/s00432-021-03910-1
- By:
- Publication type:
- Article
Effects of CYP3A43 Expression on Cell Proliferation and Migration of Lung Adenocarcinoma and Its Clinical Significance.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 113, doi. 10.3390/ijms24010113
- By:
- Publication type:
- Article
Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling Pathway.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7853, doi. 10.3390/ijms23147853
- By:
- Publication type:
- Article
A postpartum enriched environment rescues impaired cognition and oxidative markers in aged mice with gestational inflammation.
- Published in:
- Brain & Behavior, 2022, v. 12, n. 12, p. 1, doi. 10.1002/brb3.2817
- By:
- Publication type:
- Article
Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2783, doi. 10.3390/cancers12102783
- By:
- Publication type:
- Article
Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 4, p. 1012, doi. 10.3390/cells9041012
- By:
- Publication type:
- Article
Phytofabrication of Nanoparticles as Novel Drugs for Anticancer Applications.
- Published in:
- Molecules, 2019, v. 24, n. 23, p. 4246, doi. 10.3390/molecules24234246
- By:
- Publication type:
- Article